Corteva, Inc. Common Stock (CTVA) is a publicly traded Basic Materials sector company. As of July 9, 2026, CTVA trades at $83.22 with a market cap of $56.97B and a P/E ratio of 49.26. CTVA moved -1.55% today. Year to date, CTVA is +25.11%; over the trailing twelve months it is +10.05%. Its 52-week range spans $53.40 to $87.69. Analyst consensus is strong buy with an average price target of $92.00. Rallies surfaces CTVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
New York AG Seeks Cleanup Funds, Penalties from Corteva, 3M, DuPont Over PFAS: New York Attorney General Letitia James filed a lawsuit on July 9 against Corteva, 3M, DuPont, Chemours and EIDP, alleging decades of concealed PFAS contamination and health risks. The suit demands companies fund statewide PFAS cleanup efforts, warn consumers, halt misleading advertising and pay damages, restitution and disgorgement of profits.
| Metric | Value |
|---|---|
| Price | $83.22 |
| Market Cap | $56.97B |
| P/E Ratio | 49.26 |
| EPS | $1.71 |
| Dividend Yield | 0.18% |
| 52-Week High | $87.69 |
| 52-Week Low | $53.40 |
| Volume | 2.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $17.89B |
| Net Income | $1.17B |
| Gross Margin | 48.56% |
11 analysts cover CTVA: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $92.00.